Altimmune, Inc.

About Altimmune, Inc.

Altimmune is a clinical stage biopharmaceutical company focused on developing peptide-based therapeutics for various health conditions.

Products & Services

Pemvidutide:A therapeutic for obesity and its comorbidities, metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD).

Specialties

Peptide-based therapeutics Obesity treatment Metabolic dysfunction-associated steatohepatitis (MASH) Alcohol use disorder (AUD) Alcohol-associated liver disease (ALD) Liver and cardiometabolic diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 75000000 MR: - FA: approximately $75 million FAN: 75000000	D: 2026-01-29 FD: 2026-01-29	1 investors
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 75000000 MR: - FA: 75 million FAN: 75000000	D: 2026-01-27 FD: 2026-01-27	1 investors
3	RT: Credit Facility T: - FT: Credit Facility	A: 100000000 MR: - FA: up to $100 million FAN: 100000000	D: 2025-05-13 FD: 2025-05-13	1 investors

Registered Direct Offering Latest

2026-01-29

$75.0M

1 investor (Pro only)

Registered Direct Offering 2026-01-27

$75.0M

Credit Facility 2025-05-13

$100.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

V

Vipin K. Garg

President And Chief Executive Officer

G

Greg Weaver

Chief Financial Officer

S

Scot Roberts

Chief Scientific Officer

M

M. Scott Harris

Chief Medical Officer

B

Bertrand Georges

Chief Technology Officer

R

Raymond Jordt

Chief Business Officer

View 72 more team members with Pro

Unlock Full Team Directory

Recent News

Altimmune, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised